CRNX
Price
$29.45
Change
+$1.02 (+3.59%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
2.69B
37 days until earnings call
ORMP
Price
$2.19
Change
+$0.09 (+4.29%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
88.24M
42 days until earnings call
Interact to see
Advertisement

CRNX vs ORMP

Header iconCRNX vs ORMP Comparison
Open Charts CRNX vs ORMPBanner chart's image
Crinetics Pharmaceuticals
Price$29.45
Change+$1.02 (+3.59%)
Volume$16.07K
Capitalization2.69B
Oramed Pharmaceuticals
Price$2.19
Change+$0.09 (+4.29%)
Volume$300
Capitalization88.24M
CRNX vs ORMP Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. ORMP commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (CRNX: $28.43 vs. ORMP: $2.10)
Brand notoriety: CRNX and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 74% vs. ORMP: 158%
Market capitalization -- CRNX: $2.69B vs. ORMP: $85.79M
CRNX [@Biotechnology] is valued at $2.69B. ORMP’s [@Biotechnology] market capitalization is $85.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 1 bullish TA indicator(s).

  • CRNX’s TA Score: 4 bullish, 6 bearish.
  • ORMP’s TA Score: 1 bullish, 8 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than ORMP.

Price Growth

CRNX (@Biotechnology) experienced а -8.11% price change this week, while ORMP (@Biotechnology) price change was -3.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +33.64%, and the average quarterly price growth was +2.14%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.69B) has a higher market cap than ORMP($88.2M). ORMP YTD gains are higher at: -13.223 vs. CRNX (-44.397). ORMP has higher annual earnings (EBITDA): -21.53M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. ORMP (131M). ORMP has less debt than CRNX: ORMP (301K) vs CRNX (50.8M). ORMP has higher revenues than CRNX: ORMP (2M) vs CRNX (760K).
CRNXORMPCRNX / ORMP
Capitalization2.69B88.2M3,054%
EBITDA-373.49M-21.53M1,735%
Gain YTD-44.397-13.223336%
P/E RatioN/A20.91-
Revenue760K2M38%
Total Cash1.27B131M973%
Total Debt50.8M301K16,877%
FUNDAMENTALS RATINGS
CRNX vs ORMP: Fundamental Ratings
CRNX
ORMP
OUTLOOK RATING
1..100
5263
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
9493
PRICE GROWTH RATING
1..100
8560
P/E GROWTH RATING
1..100
10053
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (58) in the Pharmaceuticals Other industry is somewhat better than the same rating for CRNX (92) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew somewhat faster than CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (70) in the Pharmaceuticals Major industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that CRNX’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as CRNX (94) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew similarly to CRNX’s over the last 12 months.

ORMP's Price Growth Rating (60) in the Pharmaceuticals Other industry is in the same range as CRNX (85) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew similarly to CRNX’s over the last 12 months.

ORMP's P/E Growth Rating (53) in the Pharmaceuticals Other industry is somewhat better than the same rating for CRNX (100) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew somewhat faster than CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXORMP
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 27 days ago
76%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DIISF4.170.46
+12.40%
Direct Line Insurance Group PLC
MEDIF0.05N/A
+1.80%
Medipharm Labs Corporation
NXGPF166.80N/A
N/A
Next Group Plc
AIMTF11.10N/A
N/A
Aimfinity Investment Corp I
WFSTF0.27-0.02
-7.34%
Western Forest Products Inc.

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-1.15%
XNCR - CRNX
58%
Loosely correlated
+2.67%
TRDA - CRNX
57%
Loosely correlated
+5.80%
IDYA - CRNX
55%
Loosely correlated
+0.48%
RVMD - CRNX
55%
Loosely correlated
+0.27%
DYN - CRNX
55%
Loosely correlated
-8.82%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-6.67%
BTAI - ORMP
44%
Loosely correlated
+8.84%
INO - ORMP
44%
Loosely correlated
+0.25%
MBIO - ORMP
44%
Loosely correlated
+114.64%
VERV - ORMP
44%
Loosely correlated
+0.45%
ZNTL - ORMP
43%
Loosely correlated
+2.59%
More